Related Experiment Video
Updated: May 29, 2025
Multi-Stream Perfusion Bioreactor Integrated with Outlet Fractionation for Dynamic Cell Culture
Published on: July 20, 2022
Different behaviour of target-controlled infusion pumps despite apparently using the same Schnider pharmacokinetic
Martin Soehle1, Andreas Wolter1, Marcus Thudium1
1From the Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany (MS, AW, MT, SF, MC).
Background:
Target-controlled infusion (TCI) pumps deliver an initial bolus of drug to achieve a preset drug target concentration quickly.
Objective:
We investigated whether differences exist in the initial bolus dose between different TCI pumps despite apparently using the same pharmacokinetic (PK) model.
Design:
Observational study.
Setting:
Laboratory data from a German University Hospital. Experiments were performed between February 2019 and September 2020.
Participants:
Four TCI pumps set to the Schnider model in effect-site mode with a target propofol concentration of 3.5 μg ml-1 were studied. The algorithms of two pumps employed a fixed equilibration rate constant (k e0) of 0.456 min-1 (Perfusor® Space® and Injectomat TIVA Agilia®), while the other two used a fixed time to peak concentration (t peak) of 1.6 min (Alaris® PK and Syramed® μSP6000). Pump performance was assessed on 13 virtual patients with different combinations of age, sex, height and weight: the initial propofol dose injected was measured on a high precision scale.
Main Outcome Measures:
Propofol bolus dose, as if delivered for anaesthesia induction.
Results:
A small difference in propofol bolus doses was observed for some simulations: for example, 56.4 ± 1.2 and 59.7 ± 0.2 mg with a Syramed μSP6000 and an Alaris pharmacokinetic pump, respectively, in a virtual 54-year old man with a height of 170 cm and a weight of 74 kg. In contrast, significant differences were found in other simulated patients: for example, 72.0 ± 1.0 and 111.9 ± 1.2 mg (P < 0.001) using a Perfusor Space and an Alaris TCI pump in a virtual 60-year-old, obese man with a height of 182 cm and a weight of 139 kg.
Conclusions:
Discrepancies in the initial bolus dose can be explained by differences in k e0. Anaesthetists should be aware that differences exist in the implementation of the Schnider model between manufacturers, which could lead to disparities in the initial propofol bolus in some patients.
Related Concept Videos
01:09One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
01:15Two-Compartment Open Model: IV Infusion
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
01:18Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:14Compartment Models: Single-Compartment Model